Abstract
The concurrent use of erythropoietin beta (EPO) and radiotherapy in head and neck cancer patients has been reported by Henke et al (Lancet 2003; 362:1255–60) to correct anemia and impair cancer control. Due to the potential impact in daily clinical practice of this information a systematic critical review of the mentioned article was performed. Authors selected 10 arguments to question the contents regarding methodological and statistical aspects of the trial, and added 14 comments of controversy in more basic scientific concepts mentioned in the text as published. The panel including epidemiologist and radiation oncologists with expertise in clinical research concluded with 5 additional remarks recommending caution in interpretation of these results in terms of changes in daily practice of anemic patients support and advising not to use EPO at experimental doses or after reaching physiological concentrations of hemoglobin.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Henke M, Laszig R, Rube C, et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet. 2003;362(9392):1255–60.
Redmon CK, Colton T. Biostatistics in Clinical Trials. En Redmon CK, Colton T, editors. Structured statistical guidelines for medical journals. 1st edition. New York: John Wiley & Sons ltd; 2001, p. 441–2.
Becker A, Stadler P, Lavey RS, et al. Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys. 2000;46(2):459–66.
Hockel M, Schlenger K, Hockel S, Aral B, Schaffer U, Vaupel P. Tumor hypoxia in pelvic recurrences of cervical cancer. Int J Cancer. 1998;79(4):365–9.
Overgaard J, Horsman MR. Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Semin Radiat Oncol. 1996;6(1):10–21.
Browman GP, Wong G, Hodson, I, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med. 1993;328(3):159–63.
Lartigau E, Le Ridant AM, Lambin P, et al. Oxygenation of head and neck tumors. Cancer. 1993;71(7):2319–25.
Kelleher DK, Thews O, Vaupel P. Modulation of tumor oxygenation and radiosensitivity by erythropoietin. En: Vaupel P, Kelleher DK, editors. Tumor Hypoxia. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 1999. p. 83–90.
Fyles AW, Milosevic M, Pintilie M, Syed A, Hill RP. Anemia, hypoxia and transfusion in patients with cervix cancer: a review. Radiother Oncol 2000;57(1):13–9.
Clavo B, Pérez JL, López L, et al. Influence of haemoglobin concentration and peripheral muscle pO(2) on tumour oxygenation in advanced head and neck tumours. Radiother Oncol. 2003;66(1):71–4.
Joiner B, Hirst VK, McKeown SR, McAleer JJ, Hirst DG. The effect of recombinant human erythropoietin treatment on tumour radiosensitivity and cancer-associated anaemia in the mouse. Br J Cancer. 1993;68(4):720–6.
Thews O, Koenig R, Kelleher DK, Kutzner J, Vaupel P. Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia. Br J Cancer. 1998;78(6):752–6.
Rosti V, Pedrazzoli P, Ponchio L, et al. Effect of recombinant human erythropoietin on hematopoietic and nonhematopoietic malignant cell growthin vitro. Haematologica. 1993;78(4):208–12.
Westphal G, Niederberger E, Blum C, et al. Erythropoietin and G-CSF receptors in human tumor cells: expression and aspects regarding functionality. Tumori. 2002; 88(2):150–9.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sola, A.B., Manuel, F.A.C., Varas, B.C. et al. Erythropoietin in cancer treatment: Considerations about Henke’s article. Clin Transl Oncol 7, 332–335 (2005). https://doi.org/10.1007/BF02716548
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02716548